FINWIRES · TerminalLIVE
FINWIRES

Research Alert: CFRA Retains Hold Rating On Shares Of Organon & Co. Following Q1 Results

By

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

We keep our target price at $14.00, based on a P/E of 3.8x our 2027 EPS estimate. We lower our 2026 EPS estimate to $3.40 from $3.62 and maintain our 2027 EPS estimate at $3.71. Organon reported mixed Q1 2026 results, with revenues declining 4% Y/Y to $1,460M (-9% on a constant currency basis), reflecting headwinds across its Women's Health franchise, with sales down 16% Y/Y, particularly for Nexplanon. Yet, the company's biosimilar portfolio delivered robust growth, with revenues advancing 23% Y/Y, led by Hadlima's strong U.S. performance. Looking ahead, the successful closing of the pending Sun Pharmaceutical acquisition will be the key focus. On April 26, the company entered into a definitive merger agreement with Sun Pharmaceutical, which valued Organon at $11.75B. Joseph Morrissey, previously serving as Interim CEO, was appointed to the role on a permanent basis, which eliminates leadership uncertainty during this critical period, in our view.

Related Articles

International

OECD Says New Zealand Should Stop Frequent Changes to RBNZ Mandate

The Organisation for Economic Cooperation and Development (OECD) said New Zealand should reconsider how frequently it adjusts the Reserve Bank of New Zealand's remit, as frequent changes raise the risk of monetary policy mistakes, according to a Thursday report published by the organization.The central bank's remit is set by New Zealand's Minister of Finance and covers its operational objectives, including the target inflation range.The OECD said there have been frequent changes to the monetary policy mandate and remit since 2019, and that maintaining stability outside scheduled five-year review cycles would support the bank's credibility and enhance its ability to deliver on its inflation objectives.The organization recommended reinforcing the RBNZ's operational independence and credibility, noting that maintaining stability for the full five-year cycle until the 2028 review would support predictability, credibility, and confidence in the monetary policy regime.

$^NZ50
Asia

CITIC Securities Unit Issues $5 Million in Bonds

CITIC Securities (SHA:600030, HKG:6030) indirect unit CSI MTN issued $5 million in medium term notes.Proceeds will be used to supplement working capital, according to a Wednesday filing with the Shanghai bourse.Shares of the financial services provider were down 1% in recent trade on the Shanghai bourse and 2% on the Hong Kong bourse.

$HKG:6030$SHA:600030
Equities

Harbour Energy's Q1 Production, Revenue Grows

Harbour Energy (HBR.L) said Thursday that its production and revenue increased year over year in the three months ended March 31.The oil and gas company's production was 506,000 barrels of oil equivalent per day, compared with 500,000 boepd previously. Meanwhile, revenue increased to $3 billion from $2.8 billion.Looking ahead, the company upgraded its production guidance to 480,000 boepd to 500,000 boepd, compared with a previous range of 475,000 boepd to 500,000 boepd.

$HBR.L